cbdMD, Inc. (YCBD) Stock Analysis

Company Overview

cbdMD, Inc. (YCBD) is capitalised at $5.33M on the latest close. The company sits in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. The company reports 42 employees.

YCBD last closed at $0.48 on September 4, 2026. That is −$0.01 (−1.04%) against the previous close. The 52-week range on file runs from $0.45 to $2.56. The latest close sits 5.31% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $19.19M. Against the prior fiscal year total of $19.48M, that is a change of −1.50%. The same year closed with a net loss of $2.04M. Profit margin runs at −13.8%. That is 10.7 percentage points below the Drug Manufacturers - Specialty & Generic median of −3.14%. Earnings per share on a trailing basis come to 0.23.

Across the 4 fiscal years on file, revenue moves from $35.40M in 2022 to $19.19M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 2.07. That is 0.1 times the Drug Manufacturers - Specialty & Generic median of 19.27. Measured against sales, the shares trade at 0.25 times revenue. On price-to-sales that is 0.1 times the Drug Manufacturers - Specialty & Generic median of 2.3. 103 Drug Manufacturers - Specialty & Generic companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 2.17. Annualized volatility over the trailing 8 years is 125.09%. Over the trailing twelve months the price has returned −33.89%. Measured over 5 years, that is −77.70% a year compounded.

Growth & Income

No dividend is on file for YCBD.

The strongest complete calendar year on file is 2020 at +30.53%; the weakest is 2023 at −89.82%. Of the 8 complete calendar years on file, 1 finished higher. So far in 2026 the price is −64.74%.